Greene Barry E 4
4 · Sage Therapeutics, Inc. · Filed Jan 21, 2025
Insider Transaction Report
Form 4
Greene Barry E
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2025-01-16+174,000→ 174,000 totalExercise: $6.97Exp: 2035-01-16→ Common Stock (174,000 underlying)
Footnotes (1)
- [F1]The securities awarded on January 16, 2025 were in the form of stock options issued pursuant to the Sage Therapeutics, Inc. 2024 Equity Incentive Plan. Options to purchase 43,500 shares of common stock shall vest on the one year anniversary of January 16, 2025, with 130,500 shares vesting in 36 equal monthly installments thereafter.